Copyright
©The Author(s) 2016.
World J Gastroenterol. Dec 14, 2016; 22(46): 10093-10102
Published online Dec 14, 2016. doi: 10.3748/wjg.v22.i46.10093
Published online Dec 14, 2016. doi: 10.3748/wjg.v22.i46.10093
Clinical symptoms | Ref. |
Children with ASD have an abnormal fecal microbiota | [28,35,48,51,54,98-100] |
GI symptoms common in ASD are similar to those in IBS | [11,12] |
IBS also is associated with an abnormal fecal microbiota | [61,62,101] |
Meta-analysis shows IBS symptoms are improved by probiotic treatment. (Preliminary evidence suggests potential benefits in ASD in children and rodents models.) | [65,72,102-104] |
Mild inflammation in the GI tact may be seen in children with ASD. (There is evidence to support or refute this contention: abnormal duodenal and ileal biopsies and high plasma S100A9 but normal fecal calprotectin and lactoferrin levels) | [19,22-26,31,37] |
Probiotics reduce gut inflammation (Shown in animal models and in human diseases) | [70,105-108] |
Systemic inflammation can be also seen in children with ASD | [18,109-111] |
Immune modulation of children with ASD may reduce clinical symptoms | [41,112] |
- Citation: Navarro F, Liu Y, Rhoads JM. Can probiotics benefit children with autism spectrum disorders? World J Gastroenterol 2016; 22(46): 10093-10102
- URL: https://www.wjgnet.com/1007-9327/full/v22/i46/10093.htm
- DOI: https://dx.doi.org/10.3748/wjg.v22.i46.10093